Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome. Dickey BL, Sirak B, Martin-Gomez L, Reich RR, et al. PLoS One 2021;16:e0254161.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Dickey BL, Sirak B, Martin-Gomez L, Reich RR, et al. Oral secretory leukocyte protease inhibitor (SLPI): Associations with oropharyngeal cancer and treatment outcome. PLoS One 2021;16:e0254161.
PMID: 34214131